GlassScriptPhysician profile
Javaka K Moore
NPI 1669532347
$1,191.08
in general payments reported to CMS, 2019-2025
21 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $154 · 2021: $525 · 2022: $103 · 2023: $34.40 · 2024: $110 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $346.14 | 2019-2022 | |
| Abbvie INC. | $184.87 | 2020-2021 | |
| Optumhealth Care Solutions, LLC | $143.86 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Aspira Women'S Health INC | $76.34 | 2021 | |
| Therapeuticsmd, INC. | $45.88 | 2020-2021 | |
| Lumenis, INC | $45.79 | 2021 | |
| Avion Pharmaceuticals | $38.83 | 2021-2023 | Balcoltra |
| Astellas Pharma US INC | $37.66 | 2024 | Veozah |
| Amag Pharmaceuticals, INC. | $32.10 | 2019-2021 | |
| Coopersurgical, INC. | $28.07 | 2019-2023 | Mara Console |
| Sumitomo Pharma America, INC. | $26.39 | 2024 | Myfembree |
| Exeltis, USA INC. | $26.23 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.69 | 2021 | |
| Millicent US INC | $24.10 | 2025 | Femlyv |
| Hologic Sales and Service, LLC | $21.42 | 2025 | Aptima |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $20.65 | 2021 | |
| Lupin INC. | $19.13 | 2019 | |
| Scynexis, INC. | $16.43 | 2021 | |
| Allergan, INC. | $13.70 | 2019 | |
| Dysis Medical, INC. | $12.99 | 2021 | |
| Organon LLC | $5.81 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javaka Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.